white dischage during pregnancy and its treatment with ayurveda

Phase 2/3

Recruiting

• Conditions: upapluta yonivyapad (white discharg during pregnancy)

• Registration Number: CTRI/2018/03/012320
• Lead Sponsor: Institute of postgraduate teaching and research in ayurved

Brief Summary

The study is randomised control clinical study to evaluate efficacy of Panchavalkaladi  Varti  in group A and Panchavalkaladi ointment  in group B, group C has control group of Clotrimazole 100 mg Clindamycin100 mg vaginal suppository.The primary outcome measures the changes in subsidence of clinical signs and symptoms measured at baseline. Absence of pathogen in wet slide study,Vaginal swab culture becomes sterile and absence of recurrence during follow up. The study period is for 14 days and Panchavalkaladi  Varti  will be given in dosage of 1gm 1tab twice daily per vaginally, Panchavalkaladi ointment will be given in dosage of 5gm  twice daily per vaginally and Clotrimazole 100 mg Clindamycin100 mg vaginal suppository will be given  once daily.

xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /

Detailed Description

Not available

Study Timeline

• Study Start: 2011-11-22
• Last Update Posted: 2012-04-09

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Female
• Target Recruitment: 45

Inclusion Criteria

• After completion of first Trimester of pregnancy Age 19 to 40 years with different parity.
• White discharge present during examination.
• Inflammation present in vulva and vagina.
• Pathogens present in wet slide study and vaginal swab culture.

Exclusion Criteria

Age below 19 yrs or above 40 yrs with non specific vulvovaginitis Hypersensitivity to drug and inability to conform the protocol Women with severe physical illness, any organic pathology hepatic cardiac renal disease and any acute infection of any system Women suffering from any systemic disease like Diabetes TB STD and HIV First trimester of pregnancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Return of pH towards normal value	14 days
Improvement of signs symptoms	14 days
Absence of pathogen in wet slide study	14 days
Vaginal swab culture becomes sterile	14 days
Observation of absence of clinical features	14 days

Secondary Outcome Measures

Name	Time	Method
improvement of itching and redness in vagina	14 days

Trial Locations

Locations (1)

Institute of post graduate teaching and research in ayurveda; 🇮🇳 Jamnagar, GUJARAT, India

Institute of post graduate teaching and research in ayurveda

🇮🇳Jamnagar, GUJARAT, India

Dr priti singh verma

Principal investigator

09377020506

drpritigarg19@yahoo.com